PROKETAZINE Drug Patent Profile
When do Proketazine patents expire, and what generic alternatives are available?
Proketazine is a drug marketed by Wyeth Ayerst and is included in two NDAs.
The generic ingredient in PROKETAZINE is carphenazine maleate. There is one drug master file entry for this compound. Additional details are available on the carphenazine maleate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROKETAZINE?
- What are the global sales for PROKETAZINE?
- What is Average Wholesale Price for PROKETAZINE?
Summary for PROKETAZINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 18 |
| Patent Applications: | 468 |
| DailyMed Link: | PROKETAZINE at DailyMed |
US Patents and Regulatory Information for PROKETAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | PROKETAZINE | carphenazine maleate | CONCENTRATE;ORAL | 014173-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Wyeth Ayerst | PROKETAZINE | carphenazine maleate | TABLET;ORAL | 012768-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Wyeth Ayerst | PROKETAZINE | carphenazine maleate | TABLET;ORAL | 012768-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
